Authors:
HEINEMANN LAJ
WILLSHAHAB L
VANKESTEREN P
GOOREN LJG
QUAST A
PIETSCH H
KONRAD N
HELGE H
GRUTERS A
KNAPPE G
VENTZ M
PRANGE G
UBELHACK R
BANASCHAK K
CAVALLARI C
MACRELLI S
HINKEL GK
JUSTUS B
SAREMBE B
ABUSCHENKO E
MOESLER T
SCHINDLER AE
REGIDUR PA
MADJIDIAN K
BRAENDLE LW
KLEINKAUFHOUCKEN A
HORN HJ
MICHEL W
MORLOT M
VEISMANN S
ZIEGLER R
KREMPIEN R
ALENFELD F
HEINRICH U
SIPPELL WG
WILLE R
LASCHET R
ALEXANDER H
GLANDER HJ
SCHWARZE I
HOEPFFNER W
DIEDRICH K
SCHILL T
HEISE HR
LEHNERT H
SCHLICHTHAAR H
WEISE W
GERLOFF C
NICKEL I
BURMANNREUTER H
KRAUSE W
FLOHR J
PLEWIG G
WOLF H
SCHWARZ HP
BECKER A
SCHMIDT C
SIEGELALMASRY E
MIX M
OTTERMANN B
RANKE MB
GRAUER ML
TELLER W
HOMOKI J
WALDHAUSER F
KAISER E
BALJER E
EIDEN R
OTT F
Citation: Laj. Heinemann et al., SAFETY OF CYPROTERONE-ACETATE - REPORT OF ACTIVE SURVEILLANCE, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 169-178